Might losartan reduce sudden cardiac death in diabetic patients with hypertension?
Aronow
Wilbert S
WS
Department of Medicine, Divisions of Cardiology and Geriatrics,Westchester Medical Center and New York Medical College, Valhalla, NY 10595, USA. wsaronow@aol.com
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015897:Comorbidity; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000453:epidemiology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology; D019808:Losartan / Q000627:therapeutic use*; D008297:Male
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001262:Atenolol; D019808:Losartan